Abstract：
BACKGROUND: The use of mobile health (mHealth) apps is increasing rapidly worldwide. More and more institutions and organizations develop regulations and guidelines to enable an evidence-based and safe use. In Germany, mHealth apps fulfilling predefined criteria (Digitale Gesundheitsanwendungen [DiGA]) can be prescribed and are reimbursable by the German statutory health insurance scheme. Due to the increasing distribution of DiGA, problems and barriers should receive special attention.
OBJECTIVE: This study aims to identify the relevant problems and barriers related to the use of mHealth apps fulfilling the criteria of DiGA.
METHODS: This scoping review will follow published methodological frameworks and the PRISMA-Scr (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews) criteria. Electronic databases (MEDLINE, EMBASE, PsycINFO, and JMIR), reference lists of relevant articles, and grey literature sources will be searched. Two reviewers will assess the eligibility of the articles by a two-stage (title and abstract as well as full text) screening process. Only problems and barriers related to mHealth apps fulfilling the criteria of DiGA are included for this research. The identified studies will be categorized and analyzed with MAXQDA.
RESULTS: This scoping review gives an overview of the available evidence and identifies research gaps regarding problems and barriers related to DiGA. The results are planned to be submitted to an indexed, peer-reviewed journal in the first quarter of 2022.
CONCLUSIONS: This is the first review to identify the problems and barriers related to the use of mHealth apps fulfilling the German definition of DiGA. Nevertheless, the findings can be applied to other contexts and health care systems as well.
UNASSIGNED: DERR1-10.2196/32702.
OBJECTIVE: This study aims to identify the relevant problems and barriers related to the use of mHealth apps fulfilling the criteria of DiGA.
METHODS: This scoping review will follow published methodological frameworks and the PRISMA-Scr (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews) criteria. Electronic databases (MEDLINE, EMBASE, PsycINFO, and JMIR), reference lists of relevant articles, and grey literature sources will be searched. Two reviewers will assess the eligibility of the articles by a two-stage (title and abstract as well as full text) screening process. Only problems and barriers related to mHealth apps fulfilling the criteria of DiGA are included for this research. The identified studies will be categorized and analyzed with MAXQDA.
RESULTS: This scoping review gives an overview of the available evidence and identifies research gaps regarding problems and barriers related to DiGA. The results are planned to be submitted to an indexed, peer-reviewed journal in the first quarter of 2022.
CONCLUSIONS: This is the first review to identify the problems and barriers related to the use of mHealth apps fulfilling the German definition of DiGA. Nevertheless, the findings can be applied to other contexts and health care systems as well.
UNASSIGNED: DERR1-10.2196/32702.
摘要：
背景：移动健康（mHealth）应用程序的使用在全球范围内迅速增加。越来越多的机构和组织制定法规和准则，以实现基于证据的安全使用。在德国,满足预定义标准的mHealth应用程序（DigitaleGesundheitsanwendungen[DiGA]）可以规定并由德国法定健康保险计划报销。由于DiGA分布的增加，问题和障碍应该得到特别关注。
目的：本研究旨在确定与使用符合DiGA标准的mHealth应用程序相关的问题和障碍。
方法：本范围审查将遵循已发布的方法学框架和PRISMA-Scr（系统审查的首选报告项目和范围审查的Meta扩展分析）标准。电子数据库(MEDLINE，EMBASE,PsycINFO,和JMIR)，相关文章的参考列表，和灰色文献来源将被搜索。两名审稿人将通过两个阶段（标题和摘要以及全文）筛选过程来评估文章的资格。本研究仅包括与满足DiGA标准的mHealth应用程序相关的问题和障碍。将使用MAXQDA对确定的研究进行分类和分析。
结果：本范围审查概述了现有证据，并确定了与DiGA相关的问题和障碍的研究空白。计划将结果提交给索引，2022年第一季度的同行评审期刊。
结论：这是第一次审查，以确定与使用mHealth应用程序符合德国对DiGA的定义有关的问题和障碍。然而，这些发现也可以应用于其他环境和医疗保健系统。
UNASSIGNED：DERR1-10.2196/32702。
目的：本研究旨在确定与使用符合DiGA标准的mHealth应用程序相关的问题和障碍。
方法：本范围审查将遵循已发布的方法学框架和PRISMA-Scr（系统审查的首选报告项目和范围审查的Meta扩展分析）标准。电子数据库(MEDLINE，EMBASE,PsycINFO,和JMIR)，相关文章的参考列表，和灰色文献来源将被搜索。两名审稿人将通过两个阶段（标题和摘要以及全文）筛选过程来评估文章的资格。本研究仅包括与满足DiGA标准的mHealth应用程序相关的问题和障碍。将使用MAXQDA对确定的研究进行分类和分析。
结果：本范围审查概述了现有证据，并确定了与DiGA相关的问题和障碍的研究空白。计划将结果提交给索引，2022年第一季度的同行评审期刊。
结论：这是第一次审查，以确定与使用mHealth应用程序符合德国对DiGA的定义有关的问题和障碍。然而，这些发现也可以应用于其他环境和医疗保健系统。
UNASSIGNED：DERR1-10.2196/32702。
